New weapon for intestinal cancer methylisation – early cancer screening
Constituent cancer is the common malignant neoplasm, with new cases of colon cancer in the country being the second highest, with a higher incidence among men than women. The incidence of colon cancer increases with age, rising significantly after the age of 40-44, with the highest incidence in 80-84 years. It is therefore recommended that those over 40 years of age who have indigestion symptoms such as abdominal swelling, constipation, diarrhoea, etc., or have a direct family history of intestinal cancer should be actively screened for colon cancer.
Poor lifestyles are the main risk factors for colon cancer, including over-ingestion of red meat and processed meat, high consumption of alcohol, smoking, and family history of obesity, diabetes, inflammation and colon cancer; the main protective factors include ingestion of sufficient dietary fibres and dairy products, and reasonable physical exercise.
Clinical manifestations of colon cancer vary according to the size of the stove and the type of pathology. A number of early cases of colon cancer are clinically non-symptomatic, but as the pathologies develop and the stoves grow, a range of common symptoms of colon cancer can occur, such as an increase in the number of poops, abdominal pains, diarrhoea or constipation, intestinal infarction, as well as overall inactivity, weight loss and anaemia.
Maintaining a healthy lifestyle, providing health check-ups, tumour screening for people of different genders, ages and genetic factors, and dealing with pre-cancer pathologies can effectively reduce the incidence and mortality of colon cancer. Intestine cancer is mostly developed by intestinal flesh, which takes 5-10 years due to specific time differences between individuals, the larger the intestinal flesh, the more irregular the structure, and the greater the risk of intestinal cancer. It is therefore recommended that people over 45 years of age should undergo intestinal examination and be removed as soon as possible to avoid cancer.
For those at high risk of circulatory rectal cancer, the age at which screening begins is 40 to 74. Among them, one first-degree relative was diagnosed with colon cancer at the age of 60, or two or more first-level relatives were diagnosed with rectal cancer, recommending that the screening of colon cancer be started at the age of 10 years prior to the first-degree diagnosis, without limiting the starting age of the screening.
The colonoscopy is recommended as the preferred screening tool. Insatiable intestinal examination is an alternative means of detection of feces, colon CT etc. At present, Septin9 intestinal cancer methylisation testing has become a new option for the early screening of enteric cancer, with early detection of tumour-related methamphetamine abnormalities and expression spectrometers allowing for the detection of the corresponding tumours prior to the onset of the cancer, thus providing early prevention and treatment, as the latest and most important means of detecting tumours at an early stage, with no innovation, simplicity and high sensitivity and speciality. The 2015 Guide to Early Clostal Cancer and Endoscopy Treatment in China states that Septin9 methylation testing can be used for clinical tests for early diagnosis of colon cancer. As a result, the detection and prevention of enteric cancer can be achieved in advance by means of intestinal carcinogenization tests. Diarrhoea, consecration, wasting, inactivity, abdominal swelling for unknown reasons, or groups of people with high risk factors for enteric cancer, such as those with high lipids, high proteins, low cellulose diets, as well as those with family history of enteric cancer, are recommended every 1-3 years for the screening of the septin9 intestine carcinogenesis and, if positive, for further diagnosis in conjunction with the examination of the colon lens.
colon cancer
